NLK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.677650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.643600E-01
Normal-vs-Stage2
2.607700E-02
Normal-vs-Stage3
1.705570E-01
Normal-vs-Stage4
2.231000E-01
Stage1-vs-Stage2
2.896200E-01
Stage1-vs-Stage3
1.030780E-01
Stage1-vs-Stage4
2.919400E-01
Stage2-vs-Stage3
5.244400E-02
Stage2-vs-Stage4
9.444400E-01
Stage3-vs-Stage4
3.271700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.854620E-01
Normal-vs-AfricanAmerican
6.267200E-01
Normal-vs-Asian
2.561600E-01
Caucasian-vs-AfricanAmerican
3.210400E-01
Caucasian-vs-Asian
3.666200E-02
AfricanAmerican-vs-Asian
3.010000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.149580E-01
Normal-vs-Female
2.541800E-01
Male-vs-Female
5.703200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.230000E-01
Normal-vs-Age(41-60Yrs)
2.544600E-01
Normal-vs-Age(61-80Yrs)
1.178450E-01
Normal-vs-Age(81-100Yrs)
3.012200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.148600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.327000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.027800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.877600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.354200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.492400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.858600E-01
Normal-vs-Daily Drinker
4.794000E-02
Normal-vs-Weekly Drinker
3.609600E-02
Normal-vs-Occasional Drinker
4.963600E-01
Normal-vs-Social Drinker
4.349600E-01
Non Drinker-vs-Daily Drinker
9.594400E-01
Non Drinker-vs-Weekly Drinker
9.355800E-01
Non Drinker-vs-Occasional Drinker
2.315400E-01
Non Drinker-vs-Social Drinker
1.112550E-01
Daily Drinker-vs-Weekly Drinker
9.222600E-01
Daily Drinker-vs-Occasional Drinker
2.488200E-01
Daily Drinker-vs-Social Drinker
1.055600E-01
Weekly Drinker-vs-Occasional Drinker
2.697200E-01
Weekly Drinker-vs-Social Drinker
1.461770E-01
Occasional Drinker-vs-Social Drinker
8.982600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.912010E-01
Normal-vs-Grade 2
3.346500E-02
Normal-vs-Grade 3
1.504030E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.069700E-02
Grade 1-vs-Grade 3
4.947800E-02
Grade 1-vs-Grade 4
1.912010E-01
Grade 2-vs-Grade 3
2.487800E-01
Grade 2-vs-Grade 4
3.346500E-02
Grade 3-vs-Grade 4
1.504030E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.904350E-02
Normal-vs-NonDiabetic
2.409800E-01
Diabetic-vs-NonDiabetic
2.883900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.843900E-02
Normal-vs-NoPancreatitis
1.676960E-01
Pancreatitis-vs-NoPancreatitis
8.703400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.146000E-01
Normal-vs-N1
2.325800E-02
N0-vs-N1
2.300400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.225600E-01
Normal-vs-TP53-NonMutant
5.495200E-01
TP53-Mutant-vs-TP53-NonMutant
2.035900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
